Evidence map›Paper›PMID 32097115›Full record

SynthesisThe Permanente journal2020

Prostate Cancer and Asbestos: A Systematic Review and Meta-Analysis.

Frédéric Dutheil, Laetitia Zaragoza-Civale, Bruno Pereira, Martial Mermillod, Julien S Baker, Jeannot Schmidt, Fares Moustafa, Valentin Navel

Open access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Permanente journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 3 pooled it
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 3 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Frédéric DutheilPhysiological and Psychosocial Stress, Université Clermont Auvergne, CNRS, LaPSCo, CHU Clermont-Ferrand, University Hospital of Clermont-Ferrand, Occupational and Preventive Medicine, WittyFit, France.
Laetitia Zaragoza-CivaleOccupational and Preventive Medicine, CHU Clermont-Ferrand, University Hospital of Clermont-Ferrand, France.
Bruno PereiraBiostatistics Unit, the Clinical Research and Innovation Direction, CHU Clermont-Ferrand, University Hospital of Clermont-Ferrand, France.
Martial MermillodUniversité Grenoble Alpes, Université, Savoie Mont Blanc, CNRS, LPNC, Grenoble.
Julien S BakerDepartment of Sport, Physical Education, and Health, Centre for Health and Exercise Science Research, Hong Kong Baptist University, Kowloon Tong.
Jeannot SchmidtPhysiological and Psychosocial Stress, Université Clermont Auvergne, CNRS, LaPSCo, CHU Clermont-Ferrand, Emergency Medicine, University Hospital of Clermont-Ferrand, France.
Fares MoustafaEmergency Medicine, Université Clermont Auvergne, CHU Clermont-Ferrand, University Hospital of Clermont-Ferrand, France.
Valentin NavelOphthalmology, Université Clermont Auvergne, CHU Clermont-Ferrand, University Hospital of Clermont-Ferrand, France.
Université Clermont Auvergne · FRUniversity of Clermont Auvergne · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRCentre National de la Recherche Scientifique · FRHong Kong Baptist University · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAsbestos-related diseases and cancers represent a major public health concern.

objectiveTo conduct a systematic review and meta-analysis to demonstrate that asbestos exposure increases the risk of prostate cancer.

methodsThe PubMed, Cochrane Library, Embase, and ScienceDirect databases were searched using the keywords (prostate cancer OR prostatic neoplasm) AND (asbestos* OR crocidolite* OR chrysotile* OR amphibole* OR amosite*). To be included, articles needed to describe our primary outcome: Risk of prostate cancer after any asbestos exposure.

resultsWe included 33 studies with 15,687 cases of prostate cancer among 723,566 individuals. Asbestos exposure increased the risk of prostate cancer (effect size = 1.10, 95% confidence interval [CI] = 1.05-1.15). When we considered mode of absorption, respiratory inhalation increased the risk of prostate cancer (1.10, 95% CI = 1.05-1.14). Both environmental and occupational exposure increased the risk of prostate cancer (1.25, 95% CI = 1.01-1.48; and 1.07, 1.04-1.10, respectively). For type of fibers, the amosite group had an increased risk of prostate cancer (1.12, 95% CI = 1.05-1.19), and there were no significant results for the chrysotile/crocidolite group. The risk was higher in Europe (1.12, 95% CI = 1.05-1.19), without significant results in other continents. DISCUSSION: Asbestos exposure seems to increase prostate cancer risk. The main mechanism of absorption was respiratory. Both environmental and occupational asbestos exposure were linked to increased risk of prostate cancer.

conclusionPatients who were exposed to asbestos should possibly be encouraged to complete more frequent prostate cancer screening.

Indexed as

AsbestosAsbestos, AmphiboleAsbestos, SerpentineEnvironmental ExposureHumansIncidenceInhalation ExposureMaleOccupational ExposureProstate-Specific AntigenProstatic NeoplasmsRonidazoleAsbestosAsbestos, AmphiboleAsbestos, SerpentineProstate-Specific AntigenRonidazole

Identifiers

PMID32097115
PMCPMC7039423
OpenAlexW3011900743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.